samedan logo
 
 
spacer
home > white papers > Cleaning Validation: What do you need to consider to ensure a successful outcome? - RSSL
WHITE PAPERS
logo_RSSL.jpg

RSSL

phone +44 (0)118 918 4024
web http://www.rssl.com
email University of Reading, Whiteknights Rd, Reading, West Berkshire RG6 6LA

Cleaning Validation: What do you need to consider to ensure a successful outcome?

Cross contamination must be avoided in the Pharmaceutical industry at all costs and successful cleaning validation ensures that patients are not put at risk due to cross contamination.

The process can be divided into a number of sections each of which must be fully understood and areas of concern addressed to ensure a successful outcome across the entire process. This spans both the manufacturing and subsequent analytical and microbological support.

The data used to confirm a positive/successful cleaning validation is underpinned by the results of validated analytical methods. It is essential that these results are truly representative as patient safety is based upon the absence of equipment residues.

So what are those areas of concern, what affects your ability to get a successful outcome and what do you need to consider when carrying out a Cleaning Validation exercise?
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

SCHOTT Builds Second Melting Tank for Pharmaceutical Glass Tubing in Mainz

The international specialty glass manufacturer SCHOTT is building a second melting tank for pharmaceutical glass tubing at its main plant in Mainz, Germany. The investment volume amounts to 40 million euros. The new production facility is scheduled to go into operation in mid-2022 and will then offer 100 new jobs, 50 of which will be directly at SCHOTT. With this investment, SCHOTT is responding to the dynamically increasing global demand for glass tubing for pharmaceutical packaging.
More info >>


White Papers

Choosing the Right CMO for HPAPI Manufacturing

AMRI

Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options, but all this choice creates a problem which CMO should you pick when each is touting similar technical capabilities?
More info >>


Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement